Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have been diagnosed with breast cancer
- People who are scheduled to have a type of surgery called a modified radical mastectomy (a procedure to remove the breast and some nearby lymph nodes)
- People whose overall health before surgery falls within a moderate risk range, as classified by anaesthesia guidelines (known as ASA physical status II or III — confirm with trial site if unsure which category applies)
- People aged between 18 and 65 years
- People whose body weight relative to their height (BMI) is greater than 20 and less than 35
- People who are able to understand the study procedures and sign a written consent form
Who may not be able to join:
- People who do not wish to take part
- People whose overall health is classified as very high risk under anaesthesia guidelines (ASA physical status IV or higher)
- People whose BMI is 20 or below, or 35 or above
- People who have a known allergy or medical reason to avoid local anaesthetics, opioids, or other medications used in the study
- People who have a history of long-term (chronic) pain or who regularly use opioid pain medications
- People who have significant mental health conditions that may affect how pain is measured or reported
- People for whom regional anaesthesia (numbing a specific area of the body by injection) is not medically suitable — for example, due to an infection near the injection site, a blood clotting problem, or existing nerve damage
- People who have severe disease affecting the lungs, heart, liver, or kidneys
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sayed M Abed, MD, Associate Professor of Anesthesia and Pain Management, National Cancer Institute -- Cairo University
Phone: +20 122 680 6532
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Total 24-Hour Postoperative Morphine Consumption
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.